Dana dhuwit perusahaan quanterix.com (QTRX)

Logo grafis Quanterix Corporation (QTRX)

High patent barriers and FDA certification protect the position of Quanterix Corporation (QTRX). The company's cash position demonstrates the current level of 0.08, reflecting financial stability. Rising demand in neurology and oncology is driving sales of diagnostic systems. Revenues are based on the supply of biomarker analysis equipment to global research centers.

Quanterix Corp. - Sisa dhuwit perusahaan QTRX (periode 04.07.2022 - 21.11.2026)

QTRX (Quanterix Corp): rincian analitis lan laporan miturut indikator

Analisis komprehensif perusahaan:quanterix.com
Produk mawa merek Quanterix Corp.

Quanterix Corporation (QTRX) liquidity determines the company's resilience to market shocks and operational risks. This margin of safety is supported by stable demand for consumable chips and reagents for installed biomarker analyzers. The metric measures available capital, allowing for an assessment of the balance between financial security and capital efficiency. By analyzing the cash on hand, an investor can identify critical liquidity deviations from industry standards.